Kristin Josic
Overview
Explore the profile of Kristin Josic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
156
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ehlers J, Josic K, Yordi S, Martin A, Srivastava S, Sun J
Ophthalmol Retina
. 2024 Aug;
9(3):243-252.
PMID: 39216727
Purpose: Evaluate quantitative leakage parameters on ultrawidefield fluorescein angiography (UWF-FA) images and explore their association with Diabetic Retinopathy Severity Scale (DRSS), predominantly peripheral lesions (PPLs), visual acuity, and clinical characteristics....
2.
Lee B, Josic K, Nittala M, Velaga S, Karamat A, Srinivas S, et al.
Transl Vis Sci Technol
. 2024 Jul;
13(7):19.
PMID: 39058503
Purpose: Compare choroidal changes in ranibizumab versus panretinal photocoagulation (PRP)-treated eyes with proliferative diabetic retinopathy (PDR). Methods: DRCR Retina Network Protocol S post hoc analysis evaluated optical coherence tomography change...
3.
Maturi R, Glassman A, Josic K, Baker C, Gerstenblith A, Jampol L, et al.
JAMA
. 2023 Feb;
329(5):376-385.
PMID: 36749332
Importance: Anti-vascular endothelial growth factor (VEGF) injections in eyes with nonproliferative diabetic retinopathy (NPDR) without center-involved diabetic macular edema (CI-DME) reduce development of vision-threatening complications from diabetes over at least...
4.
Baker C, Josic K, Maguire M, Jampol L, Martin D, Rofagha S, et al.
Ophthalmology
. 2022 Dec;
130(5):533-541.
PMID: 36521571
Purpose: Evaluate the differences between clinical visual acuity (VA) as recorded in medical records and electronic Early Treatment Diabetic Retinopathy Study (eETDRS) protocol VA measurements and factors affecting the size...
5.
Sun J, Josic K, Melia M, Glassman A, Bailey C, Chalam K, et al.
Transl Vis Sci Technol
. 2021 Dec;
10(14):34.
PMID: 34967834
Purpose: Develop equations to convert Cirrus central subfield thickness (CST) to Spectralis CST equivalents and vice versa in eyes with diabetic macular edema (DME). Methods: The DRCR Retina Network Protocol...
6.
Kim J, Glassman A, Josic K, Melia M, Aiello L, Baker C, et al.
Ophthalmol Retina
. 2021 Oct;
6(4):298-307.
PMID: 34628066
Purpose: To determine if treatment with a photobiomodulation (PBM) device results in greater improvement in central subfield thickness (CST) than placebo in eyes with center-involved diabetic macular edema (CI-DME) and...
7.
Maturi R, Glassman A, Josic K, Antoszyk A, Blodi B, Jampol L, et al.
JAMA Ophthalmol
. 2021 Mar;
139(7):701-712.
PMID: 33784735
Importance: The role of anti-vascular endothelial growth factor injections for the management of nonproliferative diabetic retinopathy (NPDR) without center-involved diabetic macular edema (CI-DME) has not been clearly established. Objective: To...
8.
Glassman A, Wells 3rd J, Josic K, Maguire M, Antoszyk A, Baker C, et al.
Ophthalmology
. 2020 May;
127(9):1201-1210.
PMID: 32402554
Purpose: Assess follow-up treatment and clinical outcomes at 5 years in eyes initially treated with anti-VEGF therapy for center-involved diabetic macular edema (CI-DME) in a 2-year randomized clinical trial. Design:...